Alkermes' alixorexton met key goals in a phase 2 study for narcolepsy type 2, showing significant improvements in wakefulness and sleepiness scores.

New research reveals brain circuits follow daily schedules for memory formation, with specific hours offering advantages for ...

By Kamal Choudhury (Reuters) -Alkermes shares tumbled more than 10% on Wednesday after its experimental sleep disorder drug showed weaker-than-expected results, lowering its competitive edge against a ...

Alkermes' experimental drug significantly improved wakefulness and reduced excessive daytime sleepiness in patients with a rare sleep disorder in a mid-stage study, it said on Wednesday. Shares of the ...

Habits such as vaping, smoking and drinking alcohol are the strongest and most consistent accelerators of ageing. Smoking, ...

Society is fascinated with health, fitness and longevity. This obsession has spawned a multi-million pound industry centered ...

A new large-scale analysis of 4 million lab reports across India has revealed a worrying trend: one in two Indians has high blood sugar levels, indicating a silent but growing diabetes crisis. The ...

The weeks leading up to a major surgery can be a time of uncertainty and worry for patients, many of whom anticipate the need ...

One study, which looked at nearly 2,700 women, found that adopting healthier eating patterns for 6-12 months was a key factor ...